Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of injury-induced pancreatic neoplasia
$355,906Agnieszka Beata Bialkowska · State University New York Stony Brook · R01 · FY2023 · DK
Mechanisms of injury-induced pancreatic neoplasia
$355,906Agnieszka Beata Bialkowska · State University New York Stony Brook · R01 · FY2022 · DK
Mechanisms of injury-induced pancreatic neoplasia
$355,906Agnieszka Beata Bialkowska · State University New York Stony Brook · R01 · FY2021 · DK
Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors
$355,904Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2010 · CA
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
$355,885William G Hawkins · Washington University · P50 · FY2025 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$355,850Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2024 · CA
Role of intratumoral high endothelial venules in tumor immunity
$355,850Masanobu Komatsu · Johns Hopkins University · R01 · FY2024 · CA
The Tumor Microenvironment in Nanoparticle Delivery and Function
$355,850Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2024 · CA
Emodin as a chemopreventive agent for breast cancer
$355,830Daping Fan · University Of South Carolina At Columbia · R01 · FY2020 · CA
Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy
$355,821Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer
$355,821Adam I Marcus · Emory University · R01 · FY2018 · CA
Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging
$355,818Jinming Gao · Ut Southwestern Medical Center · R01 · FY2014 · EB
CD38 Pretargeted Radioimmunotherapy for Myeloma
$355,791Damian J. Green · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
CD38 Pretargeted Radioimmunotherapy for Myeloma
$355,791Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$355,772Lieping Chen · Yale University · R01 · FY2011 · CA
Determine the mechanisms of acquired brain-tropism
$355,742Hanlee Ji · Stanford University · U54 · FY2022 · CA
Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer
$355,739Satyanarayana Rachagani · University Of Missouri-Columbia · R01 · FY2024 · CA
Deciphering COX-2/SEMA7A dependent mechanisms of breast tumor progression.
$355,706Traci Lyons · University Of Colorado Denver · R01 · FY2018 · CA
Deciphering COX-2/SEMA7A dependent mechanisms of breast tumor progression.
$355,706Traci Lyons · University Of Colorado Denver · R01 · FY2017 · CA
Modulation of inflammasome-mediated cytokine activation by EGCG in human melanoma.
$355,706Mayumi Fujita · University Of Colorado Denver · R01 · FY2017 · CA
The GPR171 pathway in cancer immunotherapy
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2023 · CA
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.
$355,706Peter Kabos · University Of Colorado Denver · R01 · FY2017 · CA
Mechanisms underlying pro-metastatic effects of estrogen in the brain niche
$355,706Diana M. Cittelly · University Of Colorado Denver · R37 · FY2018 · CA
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
$355,706Maria L Avantaggiati · Georgetown University · R01 · FY2016 · CA
Modulation of inflammasome-mediated cytokine activation by EGCG in human melanoma.
$355,706Mayumi Fujita · University Of Colorado Denver · R01 · FY2020 · CA